Esophageal Cancer, Gastric Cancer
Conditions
Brief summary
The aim of this study was to investigate changes in abdominal tissue perfusion during adenosine vasodilation. Our hypotheses were that CT perfusion measurements are altered by changes in the circulatory system mediated by adenosine, and a more differentiated assessment of the circulatory capacity of abdominal tumours could be achieved by sequential rest and adenosine vasodilation CT perfusion measurements.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Tumour larger than 1.5 cm on diagnostic CT * Normal serum creatinine * Age above 18 * Informed written and oral consent.
Exclusion criteria
* Contrast allergy or contrast induced nephropathy * BMI \> 40 * Asthma or Chronic Obstructive Lung Disease * Heart failure (NYHA III+) * Heart conduction disorder * Atrial fibrillation * 2nd/3rd Heart block * Long QT syndrome * Wolf Parkinson White Syndrome * Moderate / severe aortic stenosis * Haemodynamic contraindications for adenosine, systolic pressure below 90
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in arterial flow during adenosine vasodilation test (CT perfusion parameter) | 0 min and 15 min |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Blood pressure during adenosine vasodilation test | 0 min and 15 min | — |
| Change in Heart rate during adenosine vasodilation test | 0 min and 15 min | — |
| Change in Area under arterial input curve during adenosine vasodilation test | 0 min and 15 min | Area Under Curve (AUC) is correlated to cardiac output |
| Change in Blood volume (CT perfusion parameter) during adenosine vasodilation test | 0 min and 15 min | — |
| Change in Permeability (CT perfusion parameter) during adenosine vasodilation test. | 0 min and 15 min | — |
Countries
Denmark